Real-World Clinical Experience With Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion In Advanced Parkinson’s Disease Patients With Mild Cognitive Impairment And History Of Psychosis
Objective: To describe the efficacy and safety of continuous subcutaneous infusion of foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson’s disease (aPD) in routine clinical practice, focusing on…Association study of genetic variants with Essential Tremor
Objective: Using a large case-control study to examine the association of rs17590046 (PPARGC1A) and rs28562175 (LOC) with ET in an Asian cohort. Background: Essential tremor…Large-Scale Shotgun Mass Spectrometry in Parkinson’s Disease Plasma Identifies Novel Biomarker Candidates
Objective: To identify novel Parkinson’s disease (PD) blood biomarkers using unbiased shotgun mass spectrometry. Background: PD is a common neurodegenerative disorder diagnosed based on its…Ntng2 Associated Neurodevelopmental Disorder A Recognisable Syndrome With Stereotypies
Objective: In this study,we wish to present the case of two siblings whom we have been monitoring for neurodevelopmental delay,who exhibit stereotypical and dyskinetic movements,and…Distinct Cognitive Profiles in Parkinson’s and Alzheimer’s Disease: Evidence from a Large Neurodegenerative Cohort
Objective: To compare cognitive profiles across patients with Parkinson’s disease and Alzheimer’s disease using standardized neuropsychological assessment. Background: Cognitive impairment is a major feature of…AI-driven quantification of oro-facial dyskinesia and kinetic entropy as a predictive biomarker for recovery in paediatric anti-NMDAR encephalitis
Objective: To develop a computer-vision-based machine learning (ML) model to objectively quantify orofacial dyskinesias (ODF) and choreoathetosis in paediatric patients, and to evaluate these "digital…Continuous Subcutaneous Foslevodopa/Foscarbidopa After Deep Brain Stimulation or Levodopa–Carbidopa Intestinal Gel: A Case Series in Advanced Parkinson’s Disease
Objective: To describe indications and short-term outcomes of FLC/FCD in PD patients previously treated with DBS and/or LCIG. Background: Advanced Parkinson's disease patients treated with…Inpatient Titration Protocol and Practical Implementation of Continuous Subcutaneous Foslevodopa/Foscarbidopa: Lessons from 28 Consecutive Cases
Objective: To describe inpatient titration methodology, dosing parameters, support services utilization, and early challenges in consecutive advanced PD patients. Background: Successful implementation of continuous subcutaneous…Associations Between Saccadic and Motoric Symptoms in Parkinson’s Disease
Objective: To explore associations between saccadic measures and i) global motor, ii) non-tremor motor, and iii) tremor severity in Parkinson’s disease (PD). Background: Impaired voluntary…Beyond Motor Fluctuations: Non-Motor and Quality-Of-Life Outcomes with Subcutaneous Foslevodopa/Foscarbidopa Infusion in Real-World Practice
Objective: To evaluate motor and non-motor outcomes, including sleep disturbances, of continuous subcutaneous foslevodopa/foscarbidopa infusion in a heterogeneous real-world cohort of patients with advanced Parkinson’s…
- « Previous Page
- 1
- …
- 189
- 190
- 191
- 192
- 193
- …
- 208
- Next Page »